Literature DB >> 4804279

Macrophages and the tumour bearing host.

R Evans.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4804279      PMCID： PMC2149057     

Source DB:  PubMed          Journal:  Br J Cancer Suppl        ISSN： 0306-9443


× No keyword cloud information.
  12 in total

1.  Mechanism of immunologically specific killing of tumour cells by macrophages.

Authors:  R Evans; P Alexander
Journal:  Nature       Date:  1972-03-24       Impact factor: 49.962

2.  Cytotoxicity of murine peritoneal macrophages in tumour allograft immunity.

Authors:  W Den Otter; R Evans; P Alexander
Journal:  Transplantation       Date:  1972-08       Impact factor: 4.939

3.  Macrophages in syngeneic animal tumours.

Authors:  R Evans
Journal:  Transplantation       Date:  1972-10       Impact factor: 4.939

4.  Role of macrophages in tumour immunity. I. Co-operation between macrophages and lymphoid cells in syngeneic tumour immunity.

Authors:  R Evans; P Alexander
Journal:  Immunology       Date:  1972-10       Impact factor: 7.397

5.  Endotoxin and double stranded RNA render macrophages cytotoxic.

Authors:  P Alexander; R Evans
Journal:  Nat New Biol       Date:  1971-07-21

6.  Cooperation of immune lymphoid cells with macrophages in tumour immunity.

Authors:  R Evans; P Alexander
Journal:  Nature       Date:  1970-11-14       Impact factor: 49.962

7.  Cellular immunity in vitro. I. Immunologically mediated enhancement of macrophage bactericidal capacity.

Authors:  H B Simon; J N Sheagren
Journal:  J Exp Med       Date:  1971-06-01       Impact factor: 14.307

8.  The influence of immunologically committed lymphoid cells on macrophage activity in vivo.

Authors:  G B Mackaness
Journal:  J Exp Med       Date:  1969-05-01       Impact factor: 14.307

9.  The effect of glucocorticosteroids on the kinetics of mononuclear phagocytes.

Authors:  J Thompson; R van Furth
Journal:  J Exp Med       Date:  1970-03-01       Impact factor: 14.307

10.  Serum mediated inhibition of the immunological reactions of the patient to his own tumour: a possible role for circulating antigen.

Authors:  G A Currie; C Basham
Journal:  Br J Cancer       Date:  1972-12       Impact factor: 7.640
View more
  8 in total

1.  Characterization of immune inducer and suppressor macrophages from the normal human lung.

Authors:  M A Spiteri; L W Poulter
Journal:  Clin Exp Immunol       Date:  1991-01       Impact factor: 4.330

2.  Influence of different cytotoxic drugs on T and B lymphocytes in children with all during remission maintenance therapy.

Authors:  J Ritter; J Oehme
Journal:  Eur J Pediatr       Date:  1976-12-09       Impact factor: 3.183

3.  [Formation of giant cells in oral squamous cell carcinoma during bleomycin treatment: enzymehistochemical, electronmicroscopic and ultrahistochemical investigations (author's transl)].

Authors:  A Burkhardt; G Bommer; J O Gebbers; W J Höltje
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1976-02-16

4.  Giant cell stromal reaction in squamous cell carcinomata. Electronmicroscopic and ultrahistochemical observations on the genesis and functional activity of multinucleated giant cells in bleomycin-induced tumor regression.

Authors:  A Burkhardt; J O Gebbers
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1977-10-07

5.  Macrophage stimulation by bacterial lipopolysaccharides. I. Cytolytic effect on tumor target cells.

Authors:  W F Doe; P M Henson
Journal:  J Exp Med       Date:  1978-08-01       Impact factor: 14.307

6.  Functional characterization of a stable, noncytolytic stage of macrophage activation in tumors.

Authors:  S W Russell; W F Doe; A T McIntosh
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307

7.  Macrophage stimulation by bacterial lipopolysaccharides. II. Evidence for differentiation signals delivered by lipid A and by a protein rich fraction of lipopolysaccharides.

Authors:  W F Doe; S T Yang; D C Morrison; S J Betz; P M Henson
Journal:  J Exp Med       Date:  1978-08-01       Impact factor: 14.307

8.  Effects of carrageenan, PVP and tumour-bearer serum on immunity induced by excision or mitomycin C-treated tumour cells in mice.

Authors:  R Kearney; R L Wu; F Orr
Journal:  Br J Cancer       Date:  1979-06       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.